欧盟官方标签名称词汇表条目 23225
P-PHENETIDINE
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 8 个有匹配的监管证据:8 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。
已检查的市场
13
有证据的市场
8
证据缺口
5
已解析的标识符
3
已解析的物质身份
CAS:156-43-4659-34-7
EC:205-855-5
成分索引记录:
8 个匹配或报告的名称
P-PHENETIDINEp-Phenetidine (4-Ethoxyaniline)p-Phenetidine (4-ethoxyaniline)p-Phenetidine; (4-Ethoxyaniline)对氨基苯乙醚(4-乙氧基苯胺) — p-Phenetidine (4-ethoxyaniline) (CAS No. 156-43-4)p-페네티딘(4-에톡시아닐린)p-fenetidina-phenetidine (4-ethoxyaniline) (CAS No. 156-43-4) p
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 未找到匹配项 | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Prohibited | 1打开记录 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Prohibited | 1打开记录 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | Prohibited | 1打开记录 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 请查看每条关联记录及其确切条件。 |
| China CN | Prohibited | 1打开记录 1 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | 请查看每条关联记录及其确切条件。 |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Prohibited | 1打开记录 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 请查看每条关联记录及其确切条件。 |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1打开记录 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | 请查看每条关联记录及其确切条件。 |
| India IN | Prohibited | 1打开记录 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条关联记录及其确切条件。 |
| Saudi Arabia SA | Prohibited | 1打开记录 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条关联记录及其确切条件。 |
没有与此筛选条件匹配的市场行。
匹配的市场记录和条件
New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026China
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025South Korea
MFDS Notice 2026-19, effective 18 March 2026Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026化学身份与性质

CAS 156-43-4PubChem CID 9076
4-Ethoxyaniline
4-ethoxyaniline is an aromatic ether that is aniline in which the hydrogen at position 4 is replaced by an ethoxy group. It is a hydrolysis metabolite of phenacetin. It has a role as a drug metabolite. It is an aromatic ether, a substituted aniline and a primary amino compound. — ChEBI
- IUPAC 名称
- 4-ethoxyaniline
- 分子式
- C8H11NO
- 分子量
- 137.18 g/mol
- 精确质量
- 137.084063974 Da
- XLogP3
- 1.2
- 拓扑极性表面积
- 35.3 Ų
- 氢键供体
- 1
- 氢键受体
- 2
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
p-PhenetidinePhenetidine4-Aminophenetolep-Ethoxyanilinep-Phenetidinp-AminophenetoleBenzenamine, 4-ethoxy-Phenethidine
另有 16 个已报告名称
1-Amino-4-ethoxybenzeneAniline, p-ethoxy-4-Phenetidine4-AminoethoxybenzeneEthyl p-aminophenol9TSL224ZSECP 5685NSC-3116CHEBI:85505RefChem:858162205-855-5Aminophenetole4-Ethoxybenzenaminep-Aminofenetolp-Fenetidin4-ETHOXY-ANILINE
外部数据库标识符
- ChEBI:CHEBI:85505
- ChEMBL:CHEMBL250969
- EPA DTXSID:DTXSID0025864
- PubMed:22940574
- PubMed:22260423
- PubMed:22101594
- PubMed:21979970
- PubMed:21589619
- PubMed:21588270
- PubMed:21582579
- PubMed:21580427
- PubMed:21579529
- PubMed:21578305
- PubMed:21578299
- PubMed:21577967
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 659-34-7PubChem CID 12119
4-(Ethylamino)phenol
- IUPAC 名称
- 4-(ethylamino)phenol
- 分子式
- C8H11NO
- 分子量
- 137.18 g/mol
- 精确质量
- 137.084063974 Da
- XLogP3
- 1.9
- 拓扑极性表面积
- 32.3 Ų
- 氢键供体
- 2
- 氢键受体
- 2
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
RefChem:1070129Phenol, 4-(ethylamino)-Ba 2831p-ethylaminophenol4-EthylaminophenolOxyphenyl-Athylamin(4-hydroxy-phenyl)-ethylamineDB-339857
另有 1 个已报告名称
EN300-75350
外部数据库标识符
- EPA DTXSID:DTXSID00984371
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定